The CRISPR Patent Ruling and Implications for Medicine
Open Access
- 13 January 2023
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 329 (6) , 461-462
Abstract
This Viewpoint discusses the CRISPR patent ruling, an ongoing patent dispute, and the implications for research and medical innovation.Keywords
This publication has 5 references indexed in Scilit:
- The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome EditingMolecular Biotechnology, 2022
- CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisNew England Journal of Medicine, 2021
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaNew England Journal of Medicine, 2021
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012